HNRNPLL stabilizes mRNA for DNA replication proteins and promotes cell cycle progression in colorectal cancer cells

被引:11
作者
Sakuma, Keiichiro [1 ]
Sasaki, Eiichi [2 ]
Kimura, Kenya [3 ]
Komori, Koji [4 ]
Shimizu, Yasuhiro [4 ]
Yatabe, Yasushi [2 ]
Aoki, Masahiro [1 ,5 ]
机构
[1] Aichi Canc Ctr, Res Inst, Div Pathophysiol, Nagoya, Aichi, Japan
[2] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan
[3] Hekinan Municipal Hosp, Dept Surg, Hekinan, Japan
[4] Aichi Canc Ctr Hosp, Dept Gastroenterol Surg, Nagoya, Aichi, Japan
[5] Nagoya Univ, Grad Sch Med, Program Funct Construct Med, Dept Canc Genet, Nagoya, Aichi, Japan
基金
日本学术振兴会;
关键词
cell cycle; colorectal cancer; DNA replication; HNRNPLL; mRNA stability; FLAP ENDONUCLEASE-1; PROLIFERATION; BINDING; BREAST; RFC3; PCNA; RIBONUCLEOPROTEIN; METASTASIS; BIOMARKER; GEMININ;
D O I
10.1111/cas.13660
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Heterogeneous nuclear ribonucleoprotein L-like (HNRNPLL), an RNA-binding protein that regulates alternative splicing of pre-mRNA, has been shown to regulate differentiation of lymphocytes, as well as metastasis of colorectal cancer cells. Here, we show that HNRNPLL promotes cell cycle progression and, hence, proliferation of colorectal cancer cells. Functional annotation analysis of those genes whose expression levels were changed threefold or more in RNA sequencing analysis between SW480 cells overexpressing HNRNPLL and those knocked down for HNRNPLL revealed enrichment of DNA replication-related genes by HNRNPLL overexpression. Among 13 genes detected in the DNA replication pathway, PCNA, RFC3 and FEN1 showed reproducible upregulation by HNRNPLL overexpression both at mRNA and at protein levels in SW480 and HT29 cells. Importantly, knockdown of any of these genes alone suppressed the proliferation-promoting effect induced by HNRNPLL overexpression. RNA-immunoprecipitation assay presented a binding of FLAG-tagged HNRNPLL to mRNA of these genes, and HNRNPLL overexpression significantly suppressed the downregulation of these genes during 12h of actinomycin D treatment, suggesting a role of HNRNPLL in mRNA stability. Finally, analysis of a public RNA sequencing dataset of clinical samples suggested a link between overexpression of HNRNPLL and that of PCNA, RFC3 and FEN1. This link was further supported by immunohistochemistry of colorectal cancer clinical samples, whereas expression of CDKN1A, which is known to inhibit the cooperative function of PCNA, RFC3 and FEN1, was negatively associated with HNRNPLL expression. These results indicate that HNRNPLL stabilizes mRNA encoding regulators of DNA replication and promotes colorectal cancer cell proliferation.
引用
收藏
页码:2458 / 2468
页数:11
相关论文
共 33 条
  • [1] Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer
    Abdel-Fatah, Tarek M. A.
    Russell, Roslin
    Albarakati, Nada
    Maloney, David J.
    Dorjsuren, Dorjbal
    Rueda, Oscar M.
    Moseley, Paul
    Mohand, Vivek
    Sun, Hongmao
    Abbotts, Rachel
    Mukherjee, Abhik
    Agarwal, Devika
    Illuzzi, Jennifer L.
    Jadhave, Ajit
    Simeonov, Anton
    Ball, Graham
    Chan, Stephen
    Caldas, Carlos
    Ellis, Ian O.
    Wilson, David M., III
    Madhusudan, Srinivasan
    [J]. MOLECULAR ONCOLOGY, 2014, 8 (07) : 1326 - 1338
  • [2] Flap Endonuclease 1
    Balakrishnan, Lata
    Bambara, Robert A.
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82, 2013, 82 : 119 - 138
  • [3] Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) and elongation factor, RNA polymerase II, 2 (ELL2) are regulators of mRNA processing in plasma cells
    Benson, Micah J.
    Aijo, Tarmo
    Chang, Xing
    Gagnon, John
    Pape, Utz J.
    Anantharaman, Vivek
    Aravind, L.
    Pursiheimo, Juha-Pekka
    Oberdoerffer, Shalini
    Liu, X. Shirley
    Lahesmaa, Riitta
    Lahdesmaki, Harri
    Rao, Anjana
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (40) : 16252 - 16257
  • [4] Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors
    Bologna-Molina, Ronell
    Mosqueda-Taylor, Adalberto
    Molina-Frechero, Nelly
    Mori-Estevez, Ana-Dolores
    Sanchez-Acuna, Guillermo
    [J]. MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2013, 18 (02): : E174 - E179
  • [5] p21(Cip1/Waf1) disrupts the recruitment of human Fen1 by proliferating-cell nuclear antigen into the DNA replication complex
    Chen, JJ
    Chen, S
    Saha, P
    Dutta, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) : 11597 - 11602
  • [6] Human Replication Factor C Stimulates Flap Endonuclease 1
    Cho, Il-taeg
    Kim, Do-hyung
    Kang, Young-Hoon
    Lee, Chul-Hwan
    Amangyelid, Tamir
    Nguyen, Tuan Anh
    Hurwitz, Jerard
    Seo, Yeon-Soo
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (16) : 10387 - 10399
  • [7] The RNA-binding protein ESRP1 promotes human colorectal cancer progression
    Fagoonee, Sharmila
    Picco, Gabriele
    Orso, Francesca
    Arrigoni, Arrigo
    Longo, Dario L.
    Forni, Marco
    Scarfo, Irene
    Cassenti, Adele
    Piva, Roberto
    Cassoni, Paola
    Silengo, Lorenzo
    Tolosano, Emanuela
    Aime, Silvio
    Taverna, Daniela
    Pandolfi, Pier Paolo
    Brancaccio, Mara
    Medico, Enzo
    Altruda, Fiorella
    [J]. ONCOTARGET, 2017, 8 (06) : 10007 - 10024
  • [8] The hnRNP family: insights into their role in health and disease
    Geuens, Thomas
    Bouhy, Delphine
    Timmerman, Vincent
    [J]. HUMAN GENETICS, 2016, 135 (08) : 851 - 867
  • [9] A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation
    Grassilli, E.
    Pisano, F.
    Cialdella, A.
    Bonomo, S.
    Missaglia, C.
    Cerrito, M. G.
    Masiero, L.
    Ianzano, L.
    Giordano, F.
    Cicirelli, V.
    Narloch, R.
    D'Amato, F.
    Noli, B.
    Ferri, G. L.
    Leone, B. E.
    Stanta, G.
    Bonin, S.
    Helin, K.
    Giovannoni, R.
    Lavitrano, M.
    [J]. ONCOGENE, 2016, 35 (33) : 4368 - 4378
  • [10] Guzinska-Ustymowicz K, 2009, ANTICANCER RES, V29, P3049